Search results

The West is the dominant U.S. region for overall venture fundraising. But in key sectors like fintech and health, other regions aren’t far behind.

After holding steady in 2023, the median seed valuation has now jumped in two straight quarters, a sign that VCs are feeling optimistic about early-stage startups.

The number of startup shutdowns on Carta hit a new high in Q1, with 254 company closures—a 58% increase compared to last year.

Understand the function of the private secondary market and how companies can benefit from secondary liquidity and secondary market transactions.

Over the past five years, dilution levels have declined at every stage of startup life. This can have compounding effects for the makeup of company cap tables.

Initial data from Q2 2024 shows modest increases in median valuation and round size across much of the U.S. venture ecosystem.

In a tight market for primary venture fundraising, a historically high number of startups are turning to bridge rounds.

Carta’s new Firm Overview dashboard allows teams across the firm to share a holistic view of every portfolio company.

IPOs are the lifeblood of venture capital, but they've been few and far between in recent years. Investors are watching to see if the success of some recent high-profile listings will provide a much-needed spark.

Health and biotech VC fundraising surged in the aftermath of the COVID-19 pandemic and has stood strong against market headwinds.

After two-plus years of steady declines, the Series C market may be bouncing back.